Spinal muscular atrophy as a blueprint for precision therapy in neuromuscular disease.

Cetin B, Aliciaslan M, Erbasan E, Cesur Ergun B, Sanlioglu S

Open source

DOI
10.1017/erm.2026.10072
Published
2026 Sep 23
Container
Expert reviews in molecular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1017/erm.2026.10072,
  title = {Spinal muscular atrophy as a blueprint for precision therapy in neuromuscular disease.},
  author = {Cetin B and Aliciaslan M and Erbasan E and Cesur Ergun B and Sanlioglu S},
  year = {2026},
  journal = {Expert reviews in molecular medicine},
  doi = {10.1017/erm.2026.10072},
  url = {https://doi.org/10.1017/erm.2026.10072}
}

RIS

TY  - JOUR
TI  - Spinal muscular atrophy as a blueprint for precision therapy in neuromuscular disease.
AU  - Cetin B
AU  - Aliciaslan M
AU  - Erbasan E
AU  - Cesur Ergun B
AU  - Sanlioglu S
PY  - 2026
JO  - Expert reviews in molecular medicine
DO  - 10.1017/erm.2026.10072
UR  - https://doi.org/10.1017/erm.2026.10072
ER  - 

APA

B, C., M, A., E, E., B, C. E., & S, S. (2026). Spinal muscular atrophy as a blueprint for precision therapy in neuromuscular disease.. Expert reviews in molecular medicine. https://doi.org/10.1017/erm.2026.10072

Source records